Henry Schein, Inc. (Nasdaq: HSIC) (the “Company”), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that it expects to appoint...
/Henry%20Schein%20Inc_%20logo%20on%20phone-by%20Piotr%20Swat%20via%20Shuttestock.jpg)
Despite Henry Schein’s underperformance relative to its peers, Wall Street analysts remain moderately optimistic about the stock’s prospects.
Q3 Rundown: Henry Schein (NASDAQ:HSIC) Vs Other Dental Equipment & Technology Stocks
Company to Serve As Exclusive Distributor of Curodont ™ Repair Fluoride Plus Across All U.S. Dental Segments
Company announces smarter workflows for Dentrix and Dentrix Ascend platforms with a focus on clean claims
Zimmer Biomet, Cigna, Universal Health Services, Henry Schein, and Sotera Health Company Shares Skyrocket, What You Need To Know
1 S&P 500 Stock with Promising Prospects and 2 Facing Headwinds
Although Henry Schein has underperformed the SPX over the past 12 months, analysts maintain a cautiously optimistic stance.